Markets & Stocks

Cannabis Stocks Today — Wednesday 18 November 2026: AFC Gamma holds above $3.50

Cannabis equities sit modestly lower on Wednesday, with US markets still in pre-market trading, so the quotes below reflect Tuesday’s closing levels and some over-the-counter names may lag by a further day.

Business of Cannabis Business Brief

Cannabis equities sit modestly lower on Wednesday, with US markets still in pre-market trading, so the quotes below reflect Tuesday’s closing levels and some over-the-counter names may lag by a further day.

The AdvisorShares Pure US Cannabis ETF (MSOS) trades at $3.65, down 1.08% against its previous close, and the Amplify Alternative Harvest ETF (MJ) sits at $20.47, down 1.68%. Business of Cannabis last checked the board in Monday’s report, which Aurora led; the Canadian producer now trades at $4.52.

Breadth is weak. Of the 35 tickers in our daily stocks coverage, seven are up against their previous close, two are unchanged and 26 are lower. AFC Gamma (AFCG) leads at $3.52, up 13.92%, with MariMed (MAPS) at $0.175, up 2.94%.

Glass House Brands (GLASF) is the heaviest faller at $2.26, down 12.40%, followed by Corbus Pharmaceuticals (CRBP) at $3.01 (down 10.81%) and Incannex Healthcare (IXHL) at $1.74 (down 9.84%). Tilray (TLRY) edges up 0.43% to $2.35, while Canopy Growth (CGC) slips 2.67% to $0.5314.

Ticker Company Current Price Change ($) Change (%)
AFCG AFC Gamma $3.52 +$0.43 +13.92%
GLASF Glass House Brands $2.26 −$0.32 −12.40%
CRBP Corbus Pharmaceuticals $3.01 −$0.36 −10.81%
IXHL Incannex Healthcare $1.74 −$0.19 −9.84%
CRLBF Cresco Labs $0.4720 −$0.02 −4.65%
IIPR Innovative Industrial Properties $50.50 −$1.79 −3.42%
MAPS WM Technology $0.1750 +$0.01 +2.94%
CGC Canopy Growth $0.5314 −$0.01 −2.67%
CRON Cronos Group $3.19 −$0.08 −2.45%
OGI Organigram $0.7069 −$0.02 −2.36%
CBWTF Auxly Cannabis $2.52 +$0.05 +2.02%
ACB Aurora Cannabis $4.52 −$0.09 −1.95%
SMG Scotts Miracle-Gro $62.55 −$1.21 −1.90%
MO Altria Group $77.46 −$1.44 −1.83%
CURLF Curaleaf Holdings $7.95 −$0.14 −1.73%
STZ Constellation Brands $144.12 −$2.51 −1.71%
MJ Amplify Alternative Harvest ETF $20.47 −$0.35 −1.68%
IPW iPower $1.21 +$0.02 +1.68%
CNBS Amplify Seymour Cannabis ETF $20.93 −$0.35 −1.64%
GRWG GrowGeneration $1.20 −$0.02 −1.64%
REFI Chicago Atlantic Real Estate Finance $8.77 +$0.14 +1.62%
JUSHF Jushi Holdings $0.3840 −$0.01 −1.54%
MSOS AdvisorShares Pure US Cannabis ETF $3.65 −$0.04 −1.08%
VFF Village Farms $2.29 −$0.02 −0.87%
GTBIF Green Thumb Industries $5.96 −$0.05 −0.83%
YOLO AdvisorShares Pure Cannabis ETF $2.39 −$0.02 −0.83%
ABBV AbbVie $292.82 −$1.73 −0.59%
TLRY Tilray Brands $2.35 +$0.01 +0.43%
HITI High Tide $2.36 −$0.01 −0.42%
JAZZ Jazz Pharmaceuticals $240.71 +$0.94 +0.39%
VEXTF Vext Science $0.1196 −$0.00 −0.33%
TPB Turning Point Brands $49.51 −$0.16 −0.32%
IMCC IM Cannabis $0.4937 −$0.00 −0.26%
SNDL SNDL $1.34 $0.00 0.00%
AAWH Ascend Wellness $0.3414 $0.00 0.00%

Glass House sits at $2.26 after reporting third-quarter results on Monday. According to the company’s filing with the SEC, revenue reached $56.8 million, against $26.2 million a year earlier, on record biomass production of about 319,000 pounds. The detail behind that growth is less comfortable. An Investing.com write-up of the earnings call notes that gross margin narrowed to 26% from 34% in the prior quarter, with the company pointing to trim-heavy sales and seasonal pricing pressure. The figures we track are for the GLASF over-the-counter line; the company’s filing also lists a NYSE quotation under GLAS.

AFC Gamma, the cannabis lender, holds above $3.50 after Tuesday’s 13.92% gain. MarketBeat reports that the shares crossed their 50-day moving average of $3.27 during the session. We found no company announcement tied to Tuesday’s move. The stock has firmed since the company reported third-quarter earnings on 5 November, and MarketBeat also recorded director Leonard Tannenbaum buying 18,500 shares on 6 November.

Corbus trades at $3.01. On Monday the company presented further data from its CANYON-1 Phase 1b trial of CRB-913, an oral CB1 inverse agonist for obesity, at ObesityWeek; its SEC filing cites mean weight loss of 5% at the 60mg dose after 12 weeks and no serious psychiatric adverse events. MarketBeat reports that the company has started a Phase 3 study of its lead cancer drug and is weighing next steps for the obesity programme. Neither source explains the share price fall.

Innovative Industrial Properties (IIPR), the cannabis-focused landlord, sits at $50.50, down 3.42%. Earlier this month, TipRanks reported that the REIT had added Series B preferred stock to its at-the-market programme, with about $336.9 million left available. Fellow lender Chicago Atlantic Real Estate Finance (REFI) moves the other way, trading at $8.77, up 1.62%.

Most of Canada’s licensed producers are lower. Cronos Group (CRON) trades at $3.19, down 2.45%, Organigram (OGI) at $0.7069, down 2.36%, and Aurora (ACB) at $4.52, down 1.95%. SNDL is unchanged at $1.34 and Village Farms (VFF) sits at $2.29, down 0.87%. Charlotte’s Web (CRLBF), the hemp-derived CBD producer, trades at $0.472, down 4.65%. Incannex sits at $1.74; we found no company announcement that accounts for its move, so we describe the level only.

Among the multi-state operators, Curaleaf (CURLF) trades at $7.95 and Green Thumb Industries (GTBIF) at $5.96, both slightly lower. Policy remains the backdrop: GreenState reported on Tuesday that the White House had reaffirmed President Trump’s support for cannabis reform amid questions over rescheduling and hemp, and Lexology noted last week that final briefs were due in the federal process. Our rescheduling hub follows each step. Adjacent names are also softer, with Scotts Miracle-Gro (SMG) at $62.55, down 1.90%, and Altria (MO) at $77.46, down 1.83%. Jazz Pharmaceuticals (JAZZ), which owns the cannabis-derived epilepsy medicine Epidiolex, is one of the few gainers at $240.71, up 0.39%. For company-level detail behind these moves, our cannabis companies directory profiles the operators. Track all cannabis stocks live on the Business of Cannabis Stocks Tracker.

TopicsACBAFCGCGCCRBPCRLBFCRONCURLFGLASF

Rob Dale

Rob runs technical and SEO strategy at Business of Cannabis and has a Master’s in Clinical Exercise Physiology. He blends search know-how with a solid grasp of clinical methods to spot what actually matters in new studies and regulations. Day to day, he helps shape evidence-based explainers and features, translating data into clear, useful insights for industry pros.

More from Rob

Spotted an error, or have a tip? Contact the newsroom.

Up next · Markets & Stocks

Cannabis Stocks Today — Monday 16 November 2026: Aurora sits at $4.94

Rob Dale · 17 November 2026

More